Spyre Therapeutics, Inc.
SYRE
$75.77
$0.730.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.99% | 55.60% | -7.67% | -6.77% | -6.35% |
| Total Receivables | 153.33% | -54.55% | 88.57% | 2.94% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.42% | 54.57% | 34.89% | 465.37% | -71.26% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.78% | 54.14% | -6.35% | -5.43% | -6.36% |
|
|
|||||
| Total Current Assets | -1.78% | 54.14% | -6.35% | -5.43% | -6.36% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 0.00% |
| Total Assets | -1.78% | 54.14% | -6.35% | -5.43% | -6.36% |
|
|
|||||
| Total Accounts Payable | -36.07% | 19.40% | 100.89% | 0.62% | 453.90% |
| Total Accrued Expenses | 8.94% | 12.34% | 22.72% | -10.24% | -20.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 118.62% | 53.52% | -74.99% | 32.13% | 73.89% |
| Total Other Current Liabilities | 118.62% | 53.52% | -74.99% | 32.13% | 73.89% |
| Total Current Liabilities | 45.12% | 26.82% | -44.29% | 17.52% | 30.74% |
|
|
|||||
| Total Current Liabilities | 45.12% | 26.82% | -44.29% | 17.52% | 30.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 106.74% | 19.50% | -- | -- | -54.97% |
| Total Liabilities | 48.92% | 26.34% | -40.40% | -4.71% | -3.87% |
|
|
|||||
| Common Stock & APIC | 1.55% | 23.66% | 0.75% | 0.75% | 0.68% |
| Retained Earnings | -6.12% | -5.87% | -1.06% | -3.61% | -4.60% |
| Treasury Stock & Other | -188.26% | 9.86% | 74.23% | -33.43% | 278.89% |
| Total Common Equity | -7.94% | 86.92% | -0.22% | -8.21% | -9.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -7.94% | 86.92% | -0.22% | -8.21% | -9.72% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.21% | 57.16% | -0.15% | -5.56% | -6.80% |
|
|
|||||